Nordisk

Key Takeaways After rising in premarket trading, Novo Nordisk’s U.S.-listed shares fell after the market …

Key Takeaways Novo Nordisk’s U.S.-listed shares rose Wednesday morning as third-quarter profits beat estimates and …

Jakub Porzycki | Nurphoto | Getty Images Novo Nordisk on Wednesday reported third quarter earnings …

Key Takeaways Hims’ third-quarter results topped expectations, driven in part by revenue from its weight-loss …

Boxes of Ozempic and Wegovy made by Novo Nordisk are seen at a pharmacy. Hollie …

Lars Fruergaard Jørgensen, CEO of Novo Nordisk, speaks during an interview in New York on …

Key Takeaways Novo Nordisk CEO Lars Fruergaard Jorgensen will testify Tuesday before a Senate panel …

Key Takeaways Novo Nordisk’s U.S.-listed shares lost ground Friday after a Phase 2a trial of …

An Eli Lilly & Co. Zepbound injection pen, March 28, 2024. Bloomberg | Bloomberg | …

Key Takeaways Novo Nordisk, maker of weight-loss drugs like Ozempic and Wegovy, reported second-quarter results …

Novo Nordisk Wegovy manufactured by Novo Nordisk packaging is seen in this illustration photo taken …

<img src='https://www.investopedia.com/thmb/AIq_avuLkl5zDDidl7t0N1Y3JP0=/filters:no_upscale():max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1690265028-388edef8c47f4184bfba3e5deda32f0c.jpg' alt=' Christian Schultz / picture alliance / Getty Images ‘ title=”Novo Nordisk logo …

A box of the drug Victoza, made by Novo Nordisk Pharmaceutical, sits on a counter …

Key Takeaways Eli Lilly and Novo Nordisk shares lost ground Thursday, while shares of Viking …